NCT05604638 - Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Tenecteplase plus Tirofiban

Patients will receive a continuous intravenous infusion of tirofiban at a rate of 0.1 µg/kg per minute for 26.5 h after start of tenecteplase treatment within 90 min

DRUG

Tenecteplase plus Placebo

Patients will receive a continuous intravenous infusion of Placebo at a rate of 0.1 µg/kg per minute for 26.5 h after start of tenecteplase treatment within 90 min